Home > About us > CEO'S Review

CEO’S Review

Dear Shareholders,

It was another year of a strong all-round performance for your company – strong growth and market expansion. We hope to continue to build on this solid performance in the years ahead. While Julphar ended the year 2010 with another set of robust results, the year also saw the passing away of H H Sheikh Saqr bin Mohammed Al Qasimi, the Ruler of Ras Al Khaimah, who was not only Julphar’s founder but also among the leading founding fathers of the United Arab Emirates. We pray to Almighty Allah to keep his soul in peace and let him live in paradise along with martyrs and grant us patience. Sheikh Saqr’s vision will always guide our endeavors and we re-dedicate ourselves, once again, to forever progress on the path shown by this great leader and visionary. We pray to the Almighty Allah that we continue to benefit from the generous guidance, vision and leadership of H H Sheikh Saud bin Saqr Al Qasimi, who has succeeded Sheikh Saqr as the Supreme Council Member of the UAE and Ruler of Ras Al Khaimah.

A Year of Achievements
The year 2010 saw Julphar scale greater heights in the performance of its existing product offerings. Simultaneously, a number of positive developments augur well for the future of the company:


>  Winning of Sheikh Mohammed Bin Rashid Al Maktoum
    Business Award.
>  Continued growth in MENA in market reach, as well as
    product registrations
>  The number of registrations reached a record 3,537. Product
    re-registrations, renewals and dossier submissions continued
    to be robust.
>  Deeper penetration for Mebo in LatAm markets.
>  Progress on new production facilities on track.


These achievements are likely to have long-term implications for the company’s performance in the coming years.

 

Sheikh Mohammed Bin Rashid Al Maktoum Business Award
Julphar won the Sheikh Mohammed Bin Rashid Al Maktoum Business Award instituted by Dubai Chamber of Commerce, in the “Manufacturing” category during the year. This Award is a reaffirmation of the company’s robust performance, its underlying strong fundamentals, and its well-planned and well-executed future strategy. It is also a  recognition of our outstanding manufacturing capabilities.

 

Continued Growth in MENA

We continued to grow in the MENA region with our product offerings. We increased our product registrations during the year to 3,537 products, while spreading our registration footprint to 50 countries. The new registrations have added to our vast portfolio of product offerings, and will likely give a stronger push to our presence in our core markets.

 

Significant gains continued to be registered in many of our leading markets during the year, where Julphar further consolidated its market leadership position. Saudi Arabia, UAE, Iraq, Jordan, Afghanistan, Lebanon and Libya were among our leading markets which saw huge gains during 2010.

 

Mebo Expands its LatAm Footprint
The year saw Julphar expanding its market presence for its leading product Mebo in the Latin American market. Julphar’s famous Mebo range consists of tissue-healing, herbal products made purely of natural ingredients. With the signing of an agreement with its Latin American agent, Julphar will likely be able to widen the reach of its Mebo range of products to a number of leading countries in the region, including Argentina, Brazil and Mexico.

 

Continued Focus on Emerging Markets
The company continues to focus on expanding its presence in the emerging markets. These markets with a strong and sustained demand undercurrent are likely to be the growth drivers of the future. Julphar is looking to strengthen its presence in these markets by building on its existing relationships, widening and deepening its market penetration, and offering more varied and complex products, going forward.

 

   “The company
   continues
   to focus on
   expanding its
   presence in
   the emerging
   markets by
   building on
   its existing
   relationships,
   deepening
   its market
   penetration
   and expanding
   its product

   offerings.”

 
 
 
 

Building World-Class Facilities
In 2010, we continued executing our expansion plans with an eye on the emerging business realities. Work on our latest world-class facili􀆟 es under construction – Julphar X (creams and ointments) and Julphar XI (insulin) continued with full vigor. The new projects are expected to further widen our product offerings and bolster our market presence, especially in the diabetic care segment. Diabetes threatens to become a major disease afflicting sizeable sections of the population in the Middle East. In this background,Julphar’s foray into bulk insulin crystals production through the upcoming Julphar XI could not have been more timely.

 

Launching Off -Patent Products
The company is looking to launch some significant products which are likely to go o􀄫 -patent in the coming two or so years, to be able to leverage Julphar’s capabilities in delivering high quality generic products, its strong and wide market presence and the robust demand for these products in all its target markets. Some of the products that the company could launch in the near future are Atorvastatin, Feromax and several other new antibiotics.


Innovative Products in Future
The company is well poised to enter new therapeutic segments offering more complex and innovative products to address newer and more serious healthcare challenges. The company also aims to expand into more global markets, going forward. I take this opportunity to thank my entire global team which has constantly striven to scale newer peaks and achieve excellence. I am sure that Team Julphar will continue to reach greater heights in the years to come. Thank you all for your trust and continued support to Julphar.

Dr. Ayman Sahli
Chief Executive Officer

Go up

   

Print this page